Assessing clinical cure of empirical piperacillin/tazobactam for ESBL urinary tract infections (ACCEPT—UTI)

BACKGROUND: Data are limited regarding use of piperacillin/tazobactam for ESBL urinary tract infections (UTIs). The objective of this study was to compare clinical outcomes of patients treated empirically with piperacillin/tazobactam versus carbapenems for ESBL UTIs. METHODS: This retrospective, obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Stefanos, Sylvia S, Sakaan, Sami, Samarin, Michael, Gelfand, Michael S, Cleveland, Kerry O, Gant, Jessie, Kermeen, Sydney, Hobbs, Diana A, Hobbs, Athena L V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174203/
https://www.ncbi.nlm.nih.gov/pubmed/37180353
http://dx.doi.org/10.1093/jacamr/dlad055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174203/
https://www.ncbi.nlm.nih.gov/pubmed/37180353
http://dx.doi.org/10.1093/jacamr/dlad055

Ejemplares similares